+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bromhidrosis Disease Treatment Market by Treatment, Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011459
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bromhidrosis Disease Treatment Market grew from USD 448.67 million in 2023 to USD 489.03 million in 2024. It is expected to continue growing at a CAGR of 9.39%, reaching USD 841.04 million by 2030.

Bromhidrosis, commonly referred to as body odor, is a chronic condition characterized by an unpleasant smell emanating from the skin, primarily due to apocrine gland secretions. The scope of its treatment market includes topical applications, oral medications, surgical interventions, and emerging laser therapies. The necessity for treatments stems from the social stigma and psychological stress associated with the condition, driving a growing demand for effective solutions. Key applications are primarily dermatological and extend to personal care products for routine management. End-use scope spans individual consumers to healthcare providers and cosmetic clinics, reflecting a trend towards outpatient and in-home care solutions.

Market growth factors include increasing awareness of personal hygiene, advancements in dermatological research, and the rising prevalence of bromhidrosis due to lifestyle changes and urbanization. Moreover, the endorsement by dermatological associations and heightened consumer willingness to spend on personal care foster market expansion. Conversely, challenges include limited awareness in underdeveloped regions, the high cost of advanced therapies, and possible side effects of surgical treatments that may hamper growth. Regulatory hurdles and the time required to develop and test new products also pose significant challenges.

Potential opportunities lie in the development of novel, non-invasive treatment modalities and the integration of artificial intelligence to personalize treatments. The shift towards natural and organic product preferences presents opportunities for brands to innovate by leveraging natural ingredients. Companies can capitalize on these trends through strategic partnerships with research institutions and developing eco-friendly, sustainable products to attract environmentally conscious consumers.

Innovation in areas such as biotechnology, nanotechnology for targeted treatment delivery, and enhancing the efficacy and safety profile of existing solutions can drive business growth. The market remains dynamic, with continuous technological advancements and changing consumer preferences dictating the pace of developments. Regular market analysis and adept adaptation strategies are essential for businesses to thrive in this evolving landscape.

Understanding Market Dynamics in the Bromhidrosis Disease Treatment Market

The Bromhidrosis Disease Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing cases of bromhidrosis and kidney and liver diseases
    • Rising investments in the clinical trials and R&D activities
    • Awareness about body odor issues
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Rapid proliferation of regulatory approvals of treatment products
    • Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
  • Market Challenges
    • Product recalls and adverse health effects

Exploring Porter’s Five Forces for the Bromhidrosis Disease Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Bromhidrosis Disease Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bromhidrosis Disease Treatment Market

External macro-environmental factors deeply influence the performance of the Bromhidrosis Disease Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bromhidrosis Disease Treatment Market

The Bromhidrosis Disease Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bromhidrosis Disease Treatment Market

The Bromhidrosis Disease Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bromhidrosis Disease Treatment Market

The Bromhidrosis Disease Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bromhidrosis Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Biovencer Healthcare Pvt. Ltd., Boehringer Ingelheim International GmbH, Galderma S.A., Hikma Pharmaceuticals PLC, Ipsen Biopharmaceuticals, Inc., Johnson & Johnson, Journey Medical Corp., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Bromhidrosis Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment
    • Botox
    • Liposuction
    • Surgery
  • Indication
    • Erythrasma
    • Intertrigo
    • Trichomycosis Axillaries
    • Type 2 Diabetes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of bromhidrosis and kidney and liver diseases
5.1.1.2. Rising investments in the clinical trials and R&D activities
5.1.1.3. Awareness about body odor issues
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Rapid proliferation of regulatory approvals of treatment products
5.1.3.2. Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
5.1.4. Challenges
5.1.4.1. Product recalls and adverse health effects
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Bromhidrosis Disease Treatment Market, by Treatment
6.1. Introduction
6.2. Botox
6.3. Liposuction
6.4. Surgery
7. Bromhidrosis Disease Treatment Market, by Indication
7.1. Introduction
7.2. Erythrasma
7.3. Intertrigo
7.4. Trichomycosis Axillaries
7.5. Type 2 Diabetes
8. Americas Bromhidrosis Disease Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Bromhidrosis Disease Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BROMHIDROSIS DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BROMHIDROSIS DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BROMHIDROSIS DISEASE TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTOX, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ERYTHRASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTERTRIGO, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TRICHOMYCOSIS AXILLARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 36. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 103. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Bromhidrosis Disease Treatment market, which are profiled in this report, include:
  • AbbVie Inc.
  • Biovencer Healthcare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Galderma S.A.
  • Hikma Pharmaceuticals PLC
  • Ipsen Biopharmaceuticals, Inc.
  • Johnson & Johnson
  • Journey Medical Corp.
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Novartis AG
  • Pfizer Inc.

Methodology

Loading
LOADING...

Table Information